APO Research
Talk to an analyst

APO RESEARCH · REPORT

Optic Neuritis Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Optic Neuritis Drug Industry Growth and Trends Forecast to 2032

26 December 2025109 pages

Choose your research edition.

Industry ResearchOptic Neuritis Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Optic Neuritis Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Optic Neuritis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Optic Neuritis Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Optic Neuritis Drug Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Optic Neuritis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Optic Neuritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Optic Neuritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Optic Neuritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Optic Neuritis Drug include Sicor Societa' Italiana Corticosteroidi S.R.L, Shanghai General Pharmaceutical, Shandong Xinhua Pharmaceutical, PFIZER SA, NEWCHEM SPA, NANG KUANG PHARMACEUTICAL, HPGC, CR Zizhu and BIOFER S.P.A, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Optic Neuritis Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Optic Neuritis Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Optic Neuritis Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Optic Neuritis Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Optic Neuritis Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Optic Neuritis Drug Market by Company

Sicor Societa' Italiana Corticosteroidi S.R.L

Shanghai General Pharmaceutical

Shandong Xinhua Pharmaceutical

PFIZER SA

NEWCHEM SPA

NANG KUANG PHARMACEUTICAL

HPGC

CR Zizhu

BIOFER S.P.A

Allergan Pharmaceuticals Ireland

Optic Neuritis Drug Segment by Type

Intravenous corticosteroid

Oral corticosteroid

Other

Optic Neuritis Drug Segment by Application

Adult

Children

Optic Neuritis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Optic Neuritis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Optic Neuritis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Optic Neuritis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Optic Neuritis Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Optic Neuritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Intravenous corticosteroid Table 2. Major Company of Oral corticosteroid Table 3. Major Company of Other Table 4. Global Optic Neuritis Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Optic Neuritis Drug Sales by Type (2021-2026) & (W Units) Table 6. Global Optic Neuritis Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Optic Neuritis Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Optic Neuritis Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Optic Neuritis Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Optic Neuritis Drug Sales by Type (2027-2032) & (W Units) Table 11. Global Optic Neuritis Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Optic Neuritis Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Optic Neuritis Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Optic Neuritis Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Optic Neuritis Drug Sales by Type (2021-2026) & (W Units) Table 16. North America Optic Neuritis Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Optic Neuritis Drug Sales by Type (2021-2026) & (W Units) Table 18. Europe Optic Neuritis Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Optic Neuritis Drug Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Optic Neuritis Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Optic Neuritis Drug Sales by Type (2021-2026) & (W Units) Table 22. Latin America Optic Neuritis Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Optic Neuritis Drug Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Optic Neuritis Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Optic Neuritis Drug Industry Trends Table 26. Optic Neuritis Drug Industry Drivers Table 27. Optic Neuritis Drug Industry Opportunities and Challenges Table 28. Optic Neuritis Drug Industry Restraints Table 29. Global Optic Neuritis Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Optic Neuritis Drug Revenue Market Share by Company (2021-2026) Table 31. Global Optic Neuritis Drug Sales by Company (2021-2026) & (W Units) Table 32. Global Optic Neuritis Drug Sales Share by Company (2021-2026) Table 33. Global Optic Neuritis Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Optic Neuritis Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Optic Neuritis Drug Major Company Production Sites and Headquarters Table 36. Global Optic Neuritis Drug Company, Product Type & Application Table 37. Global Optic Neuritis Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Optic Neuritis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Optic Neuritis Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Optic Neuritis Drug Sales by Region (2021-2026) & (W Units) Table 42. Global Optic Neuritis Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Optic Neuritis Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Optic Neuritis Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Optic Neuritis Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Optic Neuritis Drug Sales by Region (2027-2032) & (W Units) Table 47. Global Optic Neuritis Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Optic Neuritis Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Optic Neuritis Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Optic Neuritis Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Optic Neuritis Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Optic Neuritis Drug Sales by Application (2021-2026) & (W Units) Table 53. Global Optic Neuritis Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Optic Neuritis Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Optic Neuritis Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Optic Neuritis Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Optic Neuritis Drug Sales by Application (2027-2032) & (W Units) Table 58. Global Optic Neuritis Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Optic Neuritis Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Optic Neuritis Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Optic Neuritis Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Optic Neuritis Drug Sales by Application (2021-2026) & (W Units) Table 63. North America Optic Neuritis Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Optic Neuritis Drug Sales by Application (2021-2026) & (W Units) Table 65. Europe Optic Neuritis Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Optic Neuritis Drug Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Optic Neuritis Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Optic Neuritis Drug Sales by Application (2021-2026) & (W Units) Table 69. Latin America Optic Neuritis Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Optic Neuritis Drug Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Optic Neuritis Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Sicor Societa' Italiana Corticosteroidi S.R.L Company Information Table 73. Sicor Societa' Italiana Corticosteroidi S.R.L Business Overview Table 74. Sicor Societa' Italiana Corticosteroidi S.R.L Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sicor Societa' Italiana Corticosteroidi S.R.L Optic Neuritis Drug Product Portfolio Table 76. Sicor Societa' Italiana Corticosteroidi S.R.L Recent Development Table 77. Shanghai General Pharmaceutical Company Information Table 78. Shanghai General Pharmaceutical Business Overview Table 79. Shanghai General Pharmaceutical Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Shanghai General Pharmaceutical Optic Neuritis Drug Product Portfolio Table 81. Shanghai General Pharmaceutical Recent Development Table 82. Shandong Xinhua Pharmaceutical Company Information Table 83. Shandong Xinhua Pharmaceutical Business Overview Table 84. Shandong Xinhua Pharmaceutical Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Shandong Xinhua Pharmaceutical Optic Neuritis Drug Product Portfolio Table 86. Shandong Xinhua Pharmaceutical Recent Development Table 87. PFIZER SA Company Information Table 88. PFIZER SA Business Overview Table 89. PFIZER SA Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. PFIZER SA Optic Neuritis Drug Product Portfolio Table 91. PFIZER SA Recent Development Table 92. NEWCHEM SPA Company Information Table 93. NEWCHEM SPA Business Overview Table 94. NEWCHEM SPA Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. NEWCHEM SPA Optic Neuritis Drug Product Portfolio Table 96. NEWCHEM SPA Recent Development Table 97. NANG KUANG PHARMACEUTICAL Company Information Table 98. NANG KUANG PHARMACEUTICAL Business Overview Table 99. NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Product Portfolio Table 101. NANG KUANG PHARMACEUTICAL Recent Development Table 102. HPGC Company Information Table 103. HPGC Business Overview Table 104. HPGC Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. HPGC Optic Neuritis Drug Product Portfolio Table 106. HPGC Recent Development Table 107. CR Zizhu Company Information Table 108. CR Zizhu Business Overview Table 109. CR Zizhu Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. CR Zizhu Optic Neuritis Drug Product Portfolio Table 111. CR Zizhu Recent Development Table 112. BIOFER S.P.A Company Information Table 113. BIOFER S.P.A Business Overview Table 114. BIOFER S.P.A Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. BIOFER S.P.A Optic Neuritis Drug Product Portfolio Table 116. BIOFER S.P.A Recent Development Table 117. Allergan Pharmaceuticals Ireland Company Information Table 118. Allergan Pharmaceuticals Ireland Business Overview Table 119. Allergan Pharmaceuticals Ireland Optic Neuritis Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Allergan Pharmaceuticals Ireland Optic Neuritis Drug Product Portfolio Table 121. Allergan Pharmaceuticals Ireland Recent Development Table 122. North America Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. North America Optic Neuritis Drug Sales by Country (2021-2026) & (W Units) Table 124. North America Optic Neuritis Drug Sales Market Share by Country (2021-2026) Table 125. North America Optic Neuritis Drug Sales Forecast by Country (2027-2032) & (W Units) Table 126. North America Optic Neuritis Drug Sales Market Share Forecast by Country (2027-2032) Table 127. North America Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Optic Neuritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Optic Neuritis Drug Market Share by Country (2021-2026) Table 130. North America Optic Neuritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Optic Neuritis Drug Market Share Forecast by Country (2027-2032) Table 132. Europe Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Europe Optic Neuritis Drug Sales by Country (2021-2026) & (W Units) Table 134. Europe Optic Neuritis Drug Sales Market Share by Country (2021-2026) Table 135. Europe Optic Neuritis Drug Sales Forecast by Country (2027-2032) & (W Units) Table 136. Europe Optic Neuritis Drug Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Optic Neuritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Optic Neuritis Drug Market Share by Country (2021-2026) Table 140. Europe Optic Neuritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Optic Neuritis Drug Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Optic Neuritis Drug Sales by Country (2021-2026) & (W Units) Table 144. Asia-Pacific Optic Neuritis Drug Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Optic Neuritis Drug Sales Forecast by Country (2027-2032) & (W Units) Table 146. Asia-Pacific Optic Neuritis Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Optic Neuritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Optic Neuritis Drug Market Share by Country (2021-2026) Table 150. Asia-Pacific Optic Neuritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Optic Neuritis Drug Market Share Forecast by Country (2027-2032) Table 152. Latin America Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Latin America Optic Neuritis Drug Sales by Country (2021-2026) & (W Units) Table 154. Latin America Optic Neuritis Drug Sales Market Share by Country (2021-2026) Table 155. Latin America Optic Neuritis Drug Sales Forecast by Country (2027-2032) & (W Units) Table 156. Latin America Optic Neuritis Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Optic Neuritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Optic Neuritis Drug Market Share by Country (2021-2026) Table 160. Latin America Optic Neuritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Optic Neuritis Drug Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Optic Neuritis Drug Sales by Country (2021-2026) & (W Units) Table 164. Middle East and Africa Optic Neuritis Drug Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Optic Neuritis Drug Sales Forecast by Country (2027-2032) & (W Units) Table 166. Middle East and Africa Optic Neuritis Drug Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Optic Neuritis Drug Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Optic Neuritis Drug Market Share by Country (2021-2026) Table 170. Middle East and Africa Optic Neuritis Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Optic Neuritis Drug Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Optic Neuritis Drug Distributors List Table 175. Optic Neuritis Drug Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Optic Neuritis Drug Image Figure 2. Global Optic Neuritis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Optic Neuritis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Optic Neuritis Drug Sales (2021-2032) & (W Units) Figure 5. Intravenous corticosteroid Image Figure 6. Global Intravenous corticosteroid Sales YoY Growth (2021-2032) & (W Units) Figure 7. Oral corticosteroid Image Figure 8. Global Oral corticosteroid Sales YoY Growth (2021-2032) & (W Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Optic Neuritis Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Optic Neuritis Drug Market Share by Type 2025 VS 2032 Figure 13. North America Optic Neuritis Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Optic Neuritis Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Optic Neuritis Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Optic Neuritis Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Optic Neuritis Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Optic Neuritis Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Optic Neuritis Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Optic Neuritis Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Optic Neuritis Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Optic Neuritis Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Optic Neuritis Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Optic Neuritis Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Optic Neuritis Drug Market Share by Application 2025 VS 2032 Figure 31. North America Optic Neuritis Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Optic Neuritis Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Optic Neuritis Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Optic Neuritis Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Optic Neuritis Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Optic Neuritis Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Optic Neuritis Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Optic Neuritis Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Optic Neuritis Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Optic Neuritis Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Optic Neuritis Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Optic Neuritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Optic Neuritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Optic Neuritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Optic Neuritis Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Optic Neuritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Optic Neuritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Optic Neuritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Optic Neuritis Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Optic Neuritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Optic Neuritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Optic Neuritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Optic Neuritis Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Optic Neuritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Optic Neuritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Optic Neuritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Optic Neuritis Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Optic Neuritis Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Optic Neuritis Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Optic Neuritis Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Optic Neuritis Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Optic Neuritis Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous corticosteroid
  • Oral corticosteroid
  • Other
Applications
  • Adult
  • Children
Companies covered
  • Sicor Societa' Italiana Corticosteroidi S.R.L
  • Shanghai General Pharmaceutical
  • Shandong Xinhua Pharmaceutical
  • PFIZER SA
  • NEWCHEM SPA
  • NANG KUANG PHARMACEUTICAL
  • HPGC
  • CR Zizhu
  • BIOFER S.P.A
  • Allergan Pharmaceuticals Ireland

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Optic Neuritis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Optic Neuritis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Optic Neuritis Drug Market by Type
  6. 1.3.1 Intravenous corticosteroid
  7. 1.3.2 Oral corticosteroid
  8. 1.3.3 Other
  9. 1.4 Global Optic Neuritis Drug Market Size by Type
  10. 1.4.1 Global Optic Neuritis Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Optic Neuritis Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Optic Neuritis Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Optic Neuritis Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Optic Neuritis Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Optic Neuritis Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Optic Neuritis Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Optic Neuritis Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Optic Neuritis Drug Industry Trends
  2. 2.2 Optic Neuritis Drug Industry Drivers
  3. 2.3 Optic Neuritis Drug Industry Opportunities and Challenges
  4. 2.4 Optic Neuritis Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Optic Neuritis Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Optic Neuritis Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Optic Neuritis Drug Price (2021-2026)
  4. 3.4 Global Optic Neuritis Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Optic Neuritis Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Optic Neuritis Drug Company, Product Type & Application
  7. 3.7 Global Optic Neuritis Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Optic Neuritis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Optic Neuritis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Optic Neuritis Drug Tier 1, Tier 2, and Tier 3
4 Optic Neuritis Drug Regional Status and Outlook
  1. 4.1 Global Optic Neuritis Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Optic Neuritis Drug Historic Market Size by Region
  3. 4.2.1 Global Optic Neuritis Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Optic Neuritis Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Optic Neuritis Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Optic Neuritis Drug Forecasted Market Size by Region
  7. 4.3.1 Global Optic Neuritis Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Optic Neuritis Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Optic Neuritis Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Optic Neuritis Drug by Application
  1. 5.1 Optic Neuritis Drug Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Optic Neuritis Drug Market Size by Application
  5. 5.2.1 Global Optic Neuritis Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Optic Neuritis Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Optic Neuritis Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Optic Neuritis Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Optic Neuritis Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Optic Neuritis Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Optic Neuritis Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Optic Neuritis Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sicor Societa' Italiana Corticosteroidi S.R.L
  2. 6.1.1 Sicor Societa' Italiana Corticosteroidi S.R.L Company Information
  3. 6.1.2 Sicor Societa' Italiana Corticosteroidi S.R.L Business Overview
  4. 6.1.3 Sicor Societa' Italiana Corticosteroidi S.R.L Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sicor Societa' Italiana Corticosteroidi S.R.L Optic Neuritis Drug Product Portfolio
  6. 6.1.5 Sicor Societa' Italiana Corticosteroidi S.R.L Recent Developments
  7. 6.2 Shanghai General Pharmaceutical
  8. 6.2.1 Shanghai General Pharmaceutical Company Information
  9. 6.2.2 Shanghai General Pharmaceutical Business Overview
  10. 6.2.3 Shanghai General Pharmaceutical Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai General Pharmaceutical Optic Neuritis Drug Product Portfolio
  12. 6.2.5 Shanghai General Pharmaceutical Recent Developments
  13. 6.3 Shandong Xinhua Pharmaceutical
  14. 6.3.1 Shandong Xinhua Pharmaceutical Company Information
  15. 6.3.2 Shandong Xinhua Pharmaceutical Business Overview
  16. 6.3.3 Shandong Xinhua Pharmaceutical Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shandong Xinhua Pharmaceutical Optic Neuritis Drug Product Portfolio
  18. 6.3.5 Shandong Xinhua Pharmaceutical Recent Developments
  19. 6.4 PFIZER SA
  20. 6.4.1 PFIZER SA Company Information
  21. 6.4.2 PFIZER SA Business Overview
  22. 6.4.3 PFIZER SA Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 PFIZER SA Optic Neuritis Drug Product Portfolio
  24. 6.4.5 PFIZER SA Recent Developments
  25. 6.5 NEWCHEM SPA
  26. 6.5.1 NEWCHEM SPA Company Information
  27. 6.5.2 NEWCHEM SPA Business Overview
  28. 6.5.3 NEWCHEM SPA Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NEWCHEM SPA Optic Neuritis Drug Product Portfolio
  30. 6.5.5 NEWCHEM SPA Recent Developments
  31. 6.6 NANG KUANG PHARMACEUTICAL
  32. 6.6.1 NANG KUANG PHARMACEUTICAL Company Information
  33. 6.6.2 NANG KUANG PHARMACEUTICAL Business Overview
  34. 6.6.3 NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NANG KUANG PHARMACEUTICAL Optic Neuritis Drug Product Portfolio
  36. 6.6.5 NANG KUANG PHARMACEUTICAL Recent Developments
  37. 6.7 HPGC
  38. 6.7.1 HPGC Company Information
  39. 6.7.2 HPGC Business Overview
  40. 6.7.3 HPGC Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 HPGC Optic Neuritis Drug Product Portfolio
  42. 6.7.5 HPGC Recent Developments
  43. 6.8 CR Zizhu
  44. 6.8.1 CR Zizhu Company Information
  45. 6.8.2 CR Zizhu Business Overview
  46. 6.8.3 CR Zizhu Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CR Zizhu Optic Neuritis Drug Product Portfolio
  48. 6.8.5 CR Zizhu Recent Developments
  49. 6.9 BIOFER S.P.A
  50. 6.9.1 BIOFER S.P.A Company Information
  51. 6.9.2 BIOFER S.P.A Business Overview
  52. 6.9.3 BIOFER S.P.A Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 BIOFER S.P.A Optic Neuritis Drug Product Portfolio
  54. 6.9.5 BIOFER S.P.A Recent Developments
  55. 6.10 Allergan Pharmaceuticals Ireland
  56. 6.10.1 Allergan Pharmaceuticals Ireland Company Information
  57. 6.10.2 Allergan Pharmaceuticals Ireland Business Overview
  58. 6.10.3 Allergan Pharmaceuticals Ireland Optic Neuritis Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Allergan Pharmaceuticals Ireland Optic Neuritis Drug Product Portfolio
  60. 6.10.5 Allergan Pharmaceuticals Ireland Recent Developments
7 North America by Country
  1. 7.1 North America Optic Neuritis Drug Sales by Country
  2. 7.1.1 North America Optic Neuritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Optic Neuritis Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Optic Neuritis Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Optic Neuritis Drug Market Size by Country
  6. 7.2.1 North America Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Optic Neuritis Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Optic Neuritis Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Optic Neuritis Drug Sales by Country
  2. 8.1.1 Europe Optic Neuritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Optic Neuritis Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Optic Neuritis Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Optic Neuritis Drug Market Size by Country
  6. 8.2.1 Europe Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Optic Neuritis Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Optic Neuritis Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Optic Neuritis Drug Sales by Country
  2. 9.1.1 Asia-Pacific Optic Neuritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Optic Neuritis Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Optic Neuritis Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Optic Neuritis Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Optic Neuritis Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Optic Neuritis Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Optic Neuritis Drug Sales by Country
  2. 10.1.1 South America Optic Neuritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Optic Neuritis Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Optic Neuritis Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Optic Neuritis Drug Market Size by Country
  6. 10.2.1 South America Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Optic Neuritis Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Optic Neuritis Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Optic Neuritis Drug Sales by Country
  2. 11.1.1 Middle East and Africa Optic Neuritis Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Optic Neuritis Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Optic Neuritis Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Optic Neuritis Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Optic Neuritis Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Optic Neuritis Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Optic Neuritis Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Optic Neuritis Drug Value Chain Analysis
  2. 12.1.1 Optic Neuritis Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Optic Neuritis Drug Production Mode & Process
  7. 12.2 Optic Neuritis Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Optic Neuritis Drug Distributors
  10. 12.2.3 Optic Neuritis Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst